Fresenius Medical Care Renal Therapies Group, LLC

Fresenius Medical Care is the world's leading provider of dialysis products, services, and therapies for individuals with renal diseases. The company operates approximately 3,600 dialysis centers worldwide and serves around 292,000 patients, delivering over 44 million dialysis treatments annually. With ~110,000 employees and 35 production sites globally, Fresenius manufactures and supplies a comprehensive range of renal therapy solutions including dialysis machines, consumables, vascular access products, and related medical devices and pharmaceuticals for end-stage renal disease (ESRD) management. The company serves healthcare professionals and patients through clinic-based in-center hemodialysis, peritoneal dialysis, and home-based therapies. Fresenius holds regulatory approvals including FDA clearance and CE marking for its medical devices, with compliance to medical device regulations (MDR), ISO 13485, and REACH/SVHC standards. The organization provides training, education, and clinical support services to healthcare professionals and maintains a robust quality and regulatory affairs infrastructure globally.